Tacey X. Viegas

Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery

Tacey X. Viegas, Michael D. Bentley, J. Milton Harris et al. · Bioconjugate Chemistry · 2011 · 418 citations

Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications

Randall W. Moreadith, Tacey X. Viegas, Michael D. Bentley et al. · European Polymer Journal · 2016 · 171 citations

Neurodegenerative Diseases, Pharmaceutical Science, Polymer-drug Conjugate +9

Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor

Anna Mero, Zhihao Fang, Gianfranco Pasut et al. · Journal of Controlled Release · 2012 · 80 citations

Selective Conjugation, Engineering, Polymer-drug Conjugate +3

Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit

Karen L. Eskow Jaunarajs, David G. Standaert, Tacey X. Viegas et al. · Movement Disorders · 2013 · 67 citations · Full text

Tuning drug release from polyoxazoline-drug conjugates

J. Milton Harris, Michael D. Bentley, Randall W. Moreadith et al. · European Polymer Journal · 2019 · 49 citations

Pharmaceutical Science, Polymer-drug Conjugate, Medicine +4